Products for Research Use Only

Sifuvirtide (acetate)

CAT: 0804-HY-P10517A-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10517A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sifuvirtide (SFT) acetate is a potent HIV fusion inhibitor. Sifuvirtide acetate inhibits HIV-1 mediated cell fusion in a dose-dependent manner and is highly potent against infection by primary and laboratory-adapted HIV-1 isolates of multiple genotypes. Sifuvirtide acetate can be used in the research of anti-HIV drugs[1].
Product Name Alternative
SFT (acetate)
UNSPSC
12352209
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Purity
99.82
Smiles
O=C(C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCC(O)=O)=O)CC(C)C)=O)CC(C)C)=O)CC(O)=O)=O)CCCNC(N)=N)=O)CCC(O)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCC(O)=O)=O)CCC(N)=O)=O)CO)=O)CCC(O)=O)=O)CCC(O)=O)=O)CC(C)C)=O)[C@H](CC)C)=O)CCCNC(N)=N)=O)CC1=CC=C(O)C=C1)=O)[C@H](CC)C)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)[C@@H](C)O)=O)CC2=CC=C(O)C=C2)=O)CC(N)=O)=O)CCC(O)=O)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)CCC(O)=O)=O)CC3=CNC4=CC=CC=C34)=O)[C@@H](C)O)=O)CCC(O)=O)=O)CC5=CNC6=CC=CC=C56)=O)CO.CC(O)=O.[x]
Molecular Formula
C203H309N59O72.xC2H4O2
Molecular Weight
4727.98 (free base)
References & Citations
[1]Wang R R, et al. Sifuvirtide, a potent HIV fusion inhibitor peptide[J]. Biochemical and biophysical research communications, 2009, 382 (3) : 540-544.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported